ID   BW5147(T200-a)5.1
AC   CVCL_B391
SY   BW5147 (T200-a)5.1; BW/T200-; BWT200-; BW T200-; BW(T200-); BW/CD45-
DR   BTO; BTO:0002223
DR   Wikidata; Q54798734
RX   PubMed=2530588;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4137 ! BW5147.G.1.4.OUAR.1
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
RX   PubMed=2530588; DOI=10.1073/pnas.86.22.8959;
RA   Ostergaard H.L., Shackelford D.A., Hurley T.R., Johnson P., Hyman R.,
RA   Sefton B.M., Trowbridge I.S.;
RT   "Expression of CD45 alters phosphorylation of the lck-encoded tyrosine
RT   protein kinase in murine lymphoma T-cell lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:8959-8963(1989).
//